Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Asep Medical Holdings Inc C.ASEP

Alternate Symbol(s):  SEPSF

ASEP Medical Holdings Inc. is a Canada-based company, which is in the business of acquiring research and development assets, technologies and/or businesses in the area of life sciences and medical diagnostics. The Company’s consolidates three development-stage companies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. It provides medical devices with an anti-microbial, antifouling coating through its SafeCoat Medical Inc. The Company provides diagnostic kits for predicting the onset of severe Sepsis and organ failure through its Sepset Biosciences Inc. The Company also offers peptide technology through its ABT Innovations Inc. and covers a range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. SafeCoat Medical Inc.'s technology incorporates self-assembling biocompatible polymers combined with conjugated antimicrobial peptides.


CSE:ASEP - Post by User

Post by waves1on Jan 17, 2022 5:38pm
121 Views
Post# 34326250

Timely sepsis intervention needed to reduce mortality

Timely sepsis intervention needed to reduce mortality
Great time to get in on $ASEP.c while it's trading at a discount
 
Interesting article on sepsis treatment and the need for "timely therapeutic intervention in order to reduce mortality", which is exactly what ASEP is offering with their tests and why I think they're a promising play.
  • Sepsis diagnosis results back in 1 hour (current industry standard takes 24 hours)
  • Developed proprietary Peptide Technology applied as an early medical intervention to prevent biofilm growth & reduce inflammation
  • Test commercialization expected in mid 2022 is likely going to be a massive catalyst
https://www.contagionlive.com/view/detecting-sepsis-earlier
<< Previous
Bullboard Posts
Next >>